Skip to main content

Table 3 Performance of the various criteria currently in use to define metabolic health to predict insulin resistance, defined as Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) ≥2.5

From: Prevalence rates of metabolic health and body size phenotypes by different criteria and association with insulin resistance in a Maltese Caucasian population

Males

 

Crude Odds Ratio (p value)

Odds Ratio (p value) adjusted for BMI

NCEP-0

9.4 (p = 0.03)

6.1 (p = 0.017)

NCEP-1

10.2 (p < 0.001)

7.8 (p < 0.001)

NCEP-2

13.1 (p < 0.001)

10.2 (p < 0.001)

Doumatey et al.

12.2 (p < 0.001)

10.5 (p < 0.001)

Hamer et al.

10.1 (p < 0.001)

7.7 (p < 0.001)

Lynch et al.

16.6 (p < 0.001)

13.7 (p < 0.001)

Aguilar-Salinas et al.

18.7 (p < 0.001)

15.3 (p < 0.001)

Harmonisation criteria (Lavie et al.)

12.1 (p = 0.001)

9.1 (p = 0.003)

Females

NCEP-0

3.6 (p = 0.002)

1.8 (p = 0.22)

NCEP-1

8.3 (p < 0.001)

5.7 (p < 0.001)

NCEP-2

19.7(p < 0.001)

16.1 (p < 0.001)

Doumatey et al.

2.6 (p = 0.003)

2.4 (p = 0.008)

Hamer et al.

4.9 (p < 0.001)

2.9 (p = 0.008)

Lynch et al.

4.8 (p < 0.001)

3.2 (p = 0.001)

Aguilar-Salinas et al.

2.7 (p = 0.002)

2.3 (p = 0.014)

Harmonisation criteria (Lavie et al.)

5.7 (p < 0.001)

3.6 (p = 0.001)

  1. NCEP National Cholesterol Education Program/Adult Treatment Panel III